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to be used during a given immune
response is a daunting task because it
can only be achieved through the integra-
tion of a wealth of information collected at
both the structural and organismal levels.
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CD40L expressed on T cells plays an important role in stimulating the function of dendritic cells (DCs). In this
issue of Immunity, Johnson et al. (2009) demonstrate a role for DC-expressed CD40L in priming CD8+ T cell
responses.The ability of dendritic cells (DCs) to stimu-
late T cell responses is regulated by
external cues. Resting (immature) DCs,
which are poor activators of T cells, can
acquire potent T cell stimulatory activity
upon receipt of various signals that trigger
DC maturation. This process is accompa-
nied by increased DC expression of costi-
mulatory molecules and cytokines, which
deliver signals to T cells responding to
cognate antigenic peptides that allow
them to proliferate and differentiate into
effector cells. DC maturation can be driven
by host recognition of infection, and T cells
themselves can also modify the function of
DCs. One means of crosstalk between
T cells and DC is via interaction between
CD40, which is expressed constitutively
on DCs, and CD40L (also known as
CD154), which is expressed transiently by
activated CD4+ T cells. Triggering of
CD40 generates signals that lead to DC
maturation, with such DCs gaining an
increased capacity to stimulate CD8+
T cell responses. This pathway has been
shown to be a major mechanism by which
CD4+ T cells ‘‘help’’ CD8+ T cells and hasbeen termed DC ‘‘licensing’’ (Bennett
et al., 1998; Ridge et al., 1998; Schoen-
berger et al., 1998). However, some infec-
tious agents can elicit CD8+ T cell
responses that are independent of CD4+
T cell help, with licensingof DC presumably
occurring via a distinct mechanism. In this
context, Johnson et al. (2009) now provide
evidence that one way in which viruses
stimulate helper-independent CD8+ T cell
responses is by inducing CD40L expres-
sion on DC, which then triggers CD40
expressed on activated CD8+ T cells.
The authors’ interest in the role of
CD40L expression on non-T cells arose
from experiments investigating the ability
of antagonistic CD40L antibodies to
inhibit helper-dependent CD8+ T cell
responses in mice. Their measurements
focused on the generation of primary
cytotoxic T lymphocyte (CTL) responses,
as assessed by the in vivo elimination of
fluorescently labeled, peptide-loaded
target cells 1 week after immunization
with cell-associated ovalbumin (OVA). As
expected, anti-CD40L inhibited the anti-
ova CTL response in control mice, consis-Immunity 30tent with a role for CD40L in CD4+ T cell-
mediated DC licensing. Surprisingly,
however, anti-CD40L treatment also in-
hibited the anti-OVA CTL response upon
immunization of CD4+ T cell-deficient
mice (either MHC class II-deficient mice
or mice depleted of CD4+ T cells with
CD4 antibodies); in this model, agonistic
anti-CD40 treatment was used to replace
CD4+ T cell help. These results indicated
that CD40L expression on something
other than a CD4+ T cell could promote
CD8+ T cell priming. Subsequently, the
authors observed that splenic DCs
expressed substantial amounts of CD40L
after overnight in vitro culture, conditions
known to induce DC activation. Because
activated CD8+ T cells were shown to
express CD40, this led to the hypothesis
that DC-expressed CD40L promoted the
CTL response by binding to CD40 on
CD8+ T cells.
Evidence supporting this hypothesis
was generated in in vitro assays, in which
purified splenic DCs were used to stimu-
late allogeneic CD8+ T cells. Here,
CD40L-deficient (Cd40Ig/) DCs were, February 20, 2009 ª2009 Elsevier Inc. 171
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Figure 1. Costimulation of CTL Priming by DC-Expressed CD40L
DC can be stimulated to express CD40L by viruses, which may be triggered by the recognition of viral
nucleic acids by TLRs. CD8+ T cells responding to their specific peptide ligand are activated to express
CD40, and binding of CD40 to CD40L on the DCs promotes CTL priming.shown to stimulate less CD8+ T cell prolif-
eration than wild-type (WT) DCs, whereas
Cd40 but not Cd40Ig/ CD8+ T cells
proliferated less well than WT T cells
upon stimulation with WT DCs. The crucial
evidence, though, came from in vivo
experiments utilizing radiation bone
marrow (BM) chimeras. In the key model,
irradiated recipient mice were rescued
with BM that was a mixture of cells from
Cd40Ig/ mice and transgenic mice in
which the diphtheria toxin receptor (DTR)
was expressed under control of the
CD11c promoter. Because CD11c is pref-
erentially expressed by DCs, DCs arising
from the latter progenitors can be specifi-
cally deleted by administration of DT to
the mice. These chimeras, containing
a mixture of Cd40Ig/ DCs and
Cd40Ig+/+DTR+ DCs, were utilized in the
helper-independent model (ie, CD4-
depletion, OVA immunization and anti-
CD40 treatment). Critically, selective
depletion of Cd40Ig/ DCs by DT treat-
ment reduced the generation of CTLs,
identifying DCs as key CD40L-expressing
cells in generating this response. Addi-
tional experiments indicated that CD40
but not CD40L expression by CD8+
T cells was important.
These data demonstrated that CD40L
expression on DCs contributed to helper-
independent CTL priming when agonistic
anti-CD40 was used as a stimulus. In
accordance with this, the authors showed
that anti-CD40 treatment of DCs induced
CD40L expression. However, the question
remained as to whether the same pathway172 Immunity 30, February 20, 2009 ª2009could contribute to CD8+ T cell responses
in a more physiological setting. Support
for this idea came from the observation
that ligands of certain Toll-like receptors
(TLRs), innate pathogen recognition
receptors that can trigger DC maturation,
were also capable of inducing CD40L on
DC. Johnson et al. (2009) found that treat-
ment of DCs with ligands of TLR3 (poly IC,
a synthetic dsRNA) or TLR9 (deoxyoligo-
nucleotides containing specific unmethy-
lated CpG motifs) but not TLR2, TLR4, or
TLR7 induced CD40L expression. This
was associated with the selective ability
of TLR3 and TLR9 ligands to induce
helper-independent CTL priming, despite
the fact that each of the TLR ligands tested
induced some amount of DC maturation,
as indicated by an upregulation of a costi-
mulatory molecule (CD86). Importantly,
induction of CTLs by TLR3 and TLR9
ligands was inhibited by antagonistic
CD40L antibodies.
Finally, the authors showed that influ-
enza virus, which is capable of eliciting
a CD4+ T cell-independent CD8+ T cell
response, was able to induce CD40L
expression on DC in vitro. By contrast,
herpes simplex virus, which is unable to
stimulate helper-independent CTL
priming, failed to induce DC CD40L
expression, despite stimulating similar
amounts of CD86 expression on DCs as
influenza virus. These results suggested
that the ability of influenza to stimulate
helper-independent CD8+ T cell res-
ponses could be linked to its ability to
induce CD40L on DCs. In accordanceElsevier Inc.with this view, anti-CD40L inhibited the
CD8+ T cell response to influenza in
CD4-depleted mice.
The study of Johnson et al. (2009)
shows that in the absence of CD4+ T cell
help, induction of CD40L on DC can
promote CTL priming through triggering
of CD40 on CD8+ T cells and that this
pathway can be initiated by infectious
agents (Figure 1). Does this mechanism
also contribute to CD8+ T cell priming
when CD4+ T cells are present? Given
that crosslinking of CD40 on DC induces
CD40L expression, subsequent triggering
of CD40 on CD8+ T cells could theoreti-
cally represent part of the mechanism of
CD4+ T cell help. However, the available
data suggest that this is not the case.
Thus, Cd40/ CD8+ T cells have been
reported to produce normal primary CTL
responses to influenza virus, lymphocytic
choriomeningitits virus (LCMV), and liste-
ria monocytogenes when CD4+ T cells
are present (Lee et al., 2003; Sun and
Bevan, 2004), indicating that DC signals
to CD8+ T cells via the CD40L/CD40
pathway make little contribution to CTL
priming under optimal conditions. Rather,
CD40-mediated induction of other stimu-
latory signals, such as IL-7 (Carreno
et al., 2008), could be involved in licensing
of DCs by CD4+ T cells. In what physiolog-
ical setting might stimulation of CD8+
T cells by DC-expressed CD40L be rele-
vant? Perhaps this represents a backup
mechanism for situations in which CD4+
T cell responses are defective—which
could be due to deactivation by an infec-
tious agent (for example, a virus such as
HIV). This raises the question of whether
optimizing vaccines on the basis of DC
CD40L induction may be worthwhile in
such disease settings.
It is presently unclear why agonists of
some TLRs were able to induce DC
expression of CD40L, whereas others did
not. Was this due to quantitative differ-
ences in the strength of TLR signaling trig-
gered by the agonists used or qualitative
differences in the signaling pathways trig-
gered? Experiments assessing the role for
molecules in TLR signaling pathways in
CD40L induction will be required to
answer this question. Could TLR-induced
expression of CD40L be mediated indi-
rectly by cytokines produced downstream
of TLR signaling? A possible cytokine to
consider in this respect is type I interferon
(IFN-a and IFN-b), which can be induced
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Previewsby both TLR3 and TLR9 agonists (and
influenza virus) and which has also been
shown to stimulate CD4+ T cell-indepen-
dent priming of CTL responses (Le Bon
et al., 2003). Although type I IFN-stimu-
lated CD8+ T cell responses have been
shown to occur independently of CD40 in
the presence of CD4+ T cells, it’s possible
that this cytokine could trigger the
‘‘backup’’ pathway in the absence of
CD4+ cells. Thus, it may be of interest to
investigate the ability of type I IFN to
induce CD40L on DCs.
Finally, it will be important to determine
whether DC-expressed CD40L can affect
the function of CD40-expressing cells
other than CD8+ T cells. CD40 is constitu-
tively expressed on B cells and DCsAntiviral Response
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In this issue of Immunity, Town et a
kines during West Nile virus infecti
immune cell homing and pathogene
The endosomally located Toll-like recep-
tors (TLRs), notably TLR3, TLR7, TLR8,
and TLR9, are important in the host
response to viral nucleic acids. TLR7,
which is known to recognize single-
stranded RNA (ssRNA) viruses, and the
adaptor molecule MyD88, an essential
component of the response mediated by
all TLRs with the exception of TLR3, are
both important for viral containment. In
this issue of Immunity, Town et al. (2009)
present surprising evidence that the defi-
ciency of either TLR7 or MyD88 dramati-
cally affected leukocyte homing during
infection with the flavivirus West Nile virus
(WNV). By using an animal model to
address the specific role of TLR7 in
WNV infection, they found that mice lack-
ing TLR7 or MyD88 had increased
mortality and higher viral burdens thanthemselves, and the immunostimulatory
effects of triggering CD40 on these cells
are well recognized. In addition, CD40
can also be expressed by activated
CD4+ T cells (Bourgeois et al., 2002).
Given that activated CD8+ T cells can
express CD40L, there is the potential for
multiple levels of cellular crosstalk
involving CD40-CD40L interactions.
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those of control mice. Immune cell
homing to the brain was also diminished
in WNV-infected animals deficient in
TLR7 and MyD88, specifically the infiltra-
tion by macrophages and CD4+ and
CD8+ T cells. To further explore the mech-
anisms behind these findings, they exam-
ined systemic cytokine concentrations
in the infected mice. Surprisingly, the
amounts of the IL-12p40 (shared with
IL-23) subunit were substantially reduced
in TLR7-deficient mice, whereas type I
interferon, IL-6, and TNF concentrations
were not diminished. Because the p40
subunit is shared by both IL-12 and
IL-23, Town et al. used mice deficient in
individual subunits of IL-12 or IL-23 to
determine the specific role of each. Mice
deficient in IL-12p40 or IL-23p19, but
not IL-12p35, had decreased leukocyte
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3385–3389.oll-like receptors (TLRs) and cyto-
ed production of interleukin-23 in
homing to the brains and increased
mortality, supporting a unique role for IL-
23 in the generation of immune responses
following WNV infection.
These observations demonstrate the
dual roles of the innate immune system.
As in organisms without an adaptive
immune system, the proteins that make
up the innate immune system of mammals
have a direct role in inducing the produc-
tion of antiviral substances like type I inter-
ferons (Figure 1) that prevent virus-
induced cell damage. At the same time,
however, these same TLRs can induce
the production of host cytokines that
affect the development of the acquired
immune response and may affect leuko-
cyte trafficking following WNV infection.
The role of TLR7 in the host response to
RNA viruses has been well documented.
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